Honda® (Capsules, Tablets and capsules) Instructions for Use
Properties
Dietary supplement.
Glucosamine sulfate is one of the components for the synthesis of hyaluronic acid, which is necessary for stimulating the production of the cartilage matrix and providing its non-specific protection. It has anti-inflammatory properties.
Chondroitin sulfate serves as an additional substrate for the formation of a healthy cartilage matrix. It stimulates the formation of hyaluronan, the synthesis of proteoglycans and type II collagen, and also protects the cartilage tissue matrix from enzymatic cleavage (by suppressing hyaluronidase activity) and from the damaging effects of free radicals. It maintains the viscosity of the synovial fluid, stimulates cartilage repair mechanisms, and suppresses the activity of enzymes (elastases, hyaluronidases) that break down cartilage.
As a result of the action of the combination of glucosamine and chondroitin sulfate, joint mobility improves, the effectiveness of the main therapy increases, and the need for the use of painkillers and anti-inflammatory drugs decreases.
Collagen and hyaluronic acid, which may be part of the products, are contained in large quantities in cartilage, tendons, and synovial fluid. Vitamin C, B vitamins, vitamin E, and trace elements act in accordance with their biological properties.
Scope of Application
Recommended as an additional remedy for inflammatory and degenerative diseases of the joints and spine.
ICD codes
| ICD-10 code | Indication |
| M13.9 | Arthritis, unspecified |
| M15 | Polyosteoarthritis |
| M47 | Spondylosis |
| ICD-11 code | Indication |
| FA05 | Polyosteoarthritis |
| FA2Z | Inflammatory arthropathies, unspecified |
| FA8Z | Degenerative disease of spine, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Capsules
Individual, depending on the product used.
Side effects
Possible allergic reactions.
Contraindications
Hypersensitivity to the components of the product used.
Use during pregnancy and breastfeeding
Contraindicated for use during pregnancy and breastfeeding.
Special instructions
This is not a medicinal product.
Consult a doctor before using the product.
Do not exceed the recommended dose of the product used.
In children, use only dietary supplements intended for the corresponding age group.
Tablets and capsules
Adults: 2 capsules (tablets) 2 times a day with meals. The duration of intake is at least 30 days.
This is not a medicine.
Contraindications
Individual intolerance to the components, pregnancy, breastfeeding. It is recommended to consult a doctor before use.
Use during pregnancy and breastfeeding
Contraindicated during pregnancy and lactation.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Capsules
Marketing Authorization Holder
Evalar, CJSC (Russia)
Dosage Form
| Honda® | Capsules |
Dosage Form, Packaging, and Product Composition
Capsules 350 mg.
Capsules
Tablets
Tablets, coated
Marketing Authorization Holder
Evalar, CJSC (Russia)
Dosage Forms
| Honda® | Capsules | |
| Tablets | ||
| Tablets, coated |
Dosage Form, Packaging, and Product Composition
Composition glucosamine hydrochloride, chondroitin sulfate, white willow bark extract, burdock root extract, E460, E470, E461, E464, E171, E433, E1521.
Content of biologically active substances per 1 capsule: chondroitin sulfate not less than 80 mg, glucosamine (hydrochloride) not less than 80 mg.
Release form and packaging
Tablets 500 mg. Tablets, coated, 500 mg. Capsules 250 mg.
30 tablets, coated tablets, or capsules per package. 1 package in a cardboard box.
